H1N1感染症(H1N1 Infection):世界の治験レビュー(2014年下半期版)

◆英語タイトル:H1N1 Infection Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2446CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:107
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるH1N1感染症(H1N1 Infection) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - H1N1感染症(H1N1 Infection)
  - 当レポートの概要
・H1N1感染症(H1N1 Infection):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

H1N1 Infection Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “H1N1 Infection Global Clinical Trials Review, H2, 2014″ provides data on the H1N1 Infection clinical trial scenario. This report provides elemental information and data relating to the clinical trials on H1N1 Infection. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating H1N1 Infection. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
H1N1 Infection 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of H1N1 Infection to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of H1N1 Infection to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of H1N1 Infection 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in H1N1 Infection Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on H1N1 Infection 33
Oct 14, 2014: Vaxart’s Tablet Vaccine for H1N1 Influenza Generates Protective Immunity Equivalent to Injectable in Phase I Clinical Study 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
GlaxoSmithKline plc 34
Clinical Trial Overview of GlaxoSmithKline plc 34
Novartis AG 36
Clinical Trial Overview of Novartis AG 36
Sanofi 37
Clinical Trial Overview of Sanofi 37
Serum Institute of India Limited 38
Clinical Trial Overview of Serum Institute of India Limited 38
Cadila Pharmaceuticals Ltd. 39
Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 39
Vaxart, Inc. 40
Clinical Trial Overview of Vaxart, Inc. 40
Microgen Scientific Industrial Company for Immunobiological Medicines 41
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Chiltern International Ltd. 43
Clinical Trial Overview of Chiltern International Ltd. 43
Bharat Biotech International Limited 44
Clinical Trial Overview of Bharat Biotech International Limited 44
Clinical Trial Overview of Top Institutes / Government 45
The National Institute of Allergy and Infectious Diseases 45
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 45
University of British Columbia 46
Clinical Trial Overview of University of British Columbia 46
University of Rochester 47
Clinical Trial Overview of University of Rochester 47
Institut National de la Sante et de la Recherche Medicale 48
Clinical Trial Overview of Institut National de la Sante et de la Recherche Medicale 48
University Health Network 49
Clinical Trial Overview of University Health Network 49
National Heart, Lung, and Blood Institute 50
Clinical Trial Overview of National Heart, Lung, and Blood Institute 50
Hadassah Medical Organization 51
Clinical Trial Overview of Hadassah Medical Organization 51
The University of Hong Kong 52
Clinical Trial Overview of The University of Hong Kong 52
University Hospitals of Leicester NHS Trust 53
Clinical Trial Overview of University Hospitals of Leicester NHS Trust 53
Five Key Clinical Profiles 54
Appendix 105
Abbreviations 105
Definitions 105
Research Methodology 106
Secondary Research 106
About GlobalData 107
Contact Us 107
Disclaimer 107
Source 107

List of Tables
H1N1 Infection Therapeutics, Global, Clinical Trials by Region, 2014* 7
H1N1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H1N1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
H1N1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
H1N1 Infection Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
H1N1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
H1N1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
H1N1 Infection Therapeutics, Global, Clinical Trials by Phase, 2014* 21
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
H1N1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
H1N1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
H1N1 Infection Therapeutics, Global, Suspended Clinical Trials, 2014* 25
H1N1 Infection Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
H1N1 Infection Therapeutics, Global, Terminated Clinical Trials, 2014* 26
H1N1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
H1N1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
H1N1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
H1N1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
H1N1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 34
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 36
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 37
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Serum Institute of India Limited, 2014* 38
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2014* 39
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Vaxart, Inc., 2014* 40
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Microgen Scientific Industrial Company for Immunobiological Medicines, 2014* 41
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 42
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiltern International Ltd., 2014* 43
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Bharat Biotech International Limited, 2014* 44
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 45
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 46
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014* 47
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut National de la Sante et de la Recherche Medicale, 2014* 48
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2014* 49
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 50
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 51
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 52
H1N1 Infection Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospitals of Leicester NHS Trust, 2014* 53

List of Figures
H1N1 Infection Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
H1N1 Infection Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
H1N1 Infection Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
H1N1 Infection Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
H1N1 Infection Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
H1N1 Infection Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
H1N1 Infection Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
H1N1 Infection Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of H1N1 Infection to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
H1N1 Infection Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
H1N1 Infection Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
H1N1 Infection Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
H1N1 Infection Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
H1N1 Infection Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
H1N1 Infection Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
H1N1 Infection Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
H1N1 Infection Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
H1N1 Infection Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
H1N1 Infection Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 106

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[H1N1感染症(H1N1 Infection):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆